Financial reports
20-F
2023 FY
Annual report (foreign)
26 Oct 23
20-F
2022 FY
Annual report (foreign)
17 Oct 22
20-F
2021 FY
Annual report (foreign)
7 Oct 21
20-F
2020 FY
Annual report (foreign)
22 Oct 20
20-F
2019 FY
Annual report (foreign)
21 Oct 19
20-F
2018 FY
Annual report (foreign)
24 Oct 18
20-F/A
2017 FY
Annual report (foreign) (amended)
18 Dec 17
20-F
2017 FY
Annual report (foreign)
25 Oct 17
20-F
2016 FY
Annual report (foreign)
27 Oct 16
20-F
2015 FY
Annual report (foreign)
30 Oct 15
Current reports
6-K
Current report (foreign)
27 Mar 24
6-K
Current report (foreign)
26 Mar 24
6-K
Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint
21 Feb 24
6-K
Current report (foreign)
18 Jan 24
6-K
Current report (foreign)
12 Jan 24
6-K
Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
6 Dec 23
6-K
Kazia Therapeutics Announces $2 Million Registered Direct Offering
1 Dec 23
6-K
Kazia Announces Non-binding Letter of
29 Nov 23
6-K
Current report (foreign)
29 Nov 23
6-K
Current report (foreign)
21 Nov 23
Registration and prospectus
424B3
Prospectus supplement
27 Mar 24
424B3
Prospectus supplement
21 Feb 24
424B3
Prospectus supplement
5 Feb 24
F-1
Registration statement (foreign)
31 Jan 24
F-3
Shelf registration (foreign)
15 Dec 23
D
$2.00 mm in options / securities to be acquired, sold $2.00 mm, 1 investor
15 Dec 23
424B5
Prospectus supplement for primary offering
4 Dec 23
424B5
Prospectus supplement for primary offering
22 Apr 22
F-3
Shelf registration (foreign)
1 Sep 21
424B5
Prospectus supplement for primary offering
31 Mar 21
Proxies
No filings
Other
EFFECT
Notice of effectiveness
6 Feb 24
CORRESP
Correspondence with SEC
2 Feb 24
UPLOAD
Letter from SEC
1 Feb 24
EFFECT
Notice of effectiveness
26 Dec 23
CORRESP
Correspondence with SEC
21 Dec 23
UPLOAD
Letter from SEC
20 Dec 23
UPLOAD
Letter from SEC
28 Apr 22
CORRESP
Correspondence with SEC
20 Apr 22
UPLOAD
Letter from SEC
22 Mar 22
EFFECT
Notice of effectiveness
9 Sep 21
Ownership
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G
PLATINUM INVESTMENT MANAGEMENT LTD
12 Feb 24
SC 13G/A
Novogen LTD
5 Feb 16
SC 13G
Novogen LTD
2 Jul 15
SC 13G/A
Beneficial ownership report (amended)
9 Feb 15
SC 13G/A
Beneficial ownership report (amended)
6 Feb 14
SC 13D/A
Novogen LTD
25 Nov 13
SC 13D/A
Novogen LTD
4 Nov 13
SC 13D/A
Novogen LTD
22 Oct 13
SC 13D/A
AUSTIN JOSIAH T
7 Mar 13